Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
NetEase, Inc.'s published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $73.4B | |
|---|---|---|
| Revenue (ttm) | 17.2B | |
| Net income (ttm) | 4.8B | |
| EPS (ttm) | $7.42 | |
| Shares out | 3.2B | |
| P/E (trailing) | 15.2x | |
| P/E (forward) | 11.2x | |
| Dividend | $2.92 (2.60%) | |
| Volume | 670,087 | |
| Beta | 0.77 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | Trend |
|---|---|---|---|---|---|
| Period | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $96.50B | $103.47B | $105.30B | $112.63B | +5.3% |
| Gross profit | $52.77B | $63.06B | $65.81B | $72.40B | +11.1% |
| Operating income | $19.63B | $27.71B | $29.58B | $35.83B | +22.2% |
| Net income | $20.34B | $29.42B | $29.70B | $33.76B | +18.4% |
| EPS (diluted) | $30.85 | $45.25 | $45.95 | $52.40 | +19.3% |
| EBITDA | $22.49B | $30.76B | $32.00B | $38.08B | +19.2% |
| R&D | $15.04B | $16.48B | $17.52B | $17.72B | +5.6% |
| SG&A | $18.10B | $18.87B | $18.70B | $18.85B | +1.4% |
Recent company headlines from major financial publishers.
A Bull case assumes NetEase successfully diversifies its revenue away from China with global hits, leading to a valuation re-rating toward international peer multiples (18x+).
The Base case reflects continued domestic dominance and modest international progress, valued using a 15-year moat-fade model and conservative terminal growth.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 6.7% | $216 | $241 | $274 | $311 | $311 |
| 7.7% | $178 | $195 | $216 | $241 | $274 |
| 8.7% | $151 | $163 | $178 | $195 | $216 |
| 9.7% | $132 | $141 | $151 | $163 | $178 |
| 10.7% | $116 | $124 | $132 | $141 | $151 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
